PepLabo Download

Saxenda® (liraglutide) and dizziness

Dizziness on Saxenda® is usually a passing light-headed feeling in the first weeks, but the product information treats it seriously enough to mention driving. It also lists several label effects that can make you dizzy for different reasons: low blood sugar, fluid loss, lower blood pressure and a faster heart rate. This page sets out the adult and teen figures from the US, EU and Canadian documents, what a pharmacovigilance study adds, how to tell the main causes apart, the self-care steps MedlinePlus describes and the dizzy spells that need emergency care.

Published · Updated · Saxenda®: side effects by symptom · Written by the PepLabo editorial team

Dizziness in the three documents

All three regulators list dizziness for Saxenda®, and the EU places it in its common class. [1][2][3] The US and Canadian adult figures come from five placebo-controlled trials, the teen figures from one 56-week trial. [1][3]

Dizziness in Saxenda® product information (checked 20-10-2026)
Document and groupSaxenda®PlaceboNote
US label, Table 2, adults [1]6.9%5.0%Mostly in the first 12 weeks
Canadian monograph, Table 3, adults [3]233 of 3,384 (6.9%)97 of 1,941 (5.0%)Same adult pool
US label, Table 3, ages 12–17 [1]10.4%3.2%One trial, 125 vs 126 teens
EU SmPC, Table 4 and section 4.7 [2]Common—Mainly first 3 months; care with driving

A small gap in adults, a wider one in teens

In adults, dizziness was only about two points above placebo, so many dizzy spells in the trials had ordinary causes. [1] In teenagers the difference was about seven points, and dizziness was one of the more frequent reactions in that trial. [1] Teens on Saxenda® also had more low blood sugar, which may explain part of it, though the label does not draw that link. [1]

Timing is consistent across the documents. The US and Canadian labels say dizziness, fatigue, weakness, malaise and taste change were mainly reported within the first 12 weeks and often together with digestive effects, and that most were mild to moderate and short-lived. [1][3] The EU leaflet says dizziness may be felt mainly during the first three months. [2]

Four label effects that can make you dizzy

  • Low blood sugar. The Medication Guide lists dizziness or light-headedness, together with sweating, shakiness, hunger and a fast heartbeat. The risk is higher for adults with type 2 diabetes on insulin or a sulfonylurea and for teenagers. [1]
  • Fluid loss. Vomiting and diarrhoea can dehydrate you, and MedlinePlus lists dizziness among signs of severe dehydration; the label links dehydration on liraglutide to kidney injury. [1][7]
  • Lower blood pressure. In the main trial, systolic pressure fell by 4.3 mmHg on Saxenda® and 1.5 mmHg on placebo, and events of low blood pressure, including drops on standing, were reported by 1.1% against 0.5%. In four people on Saxenda®, systolic pressure dropped below 80 mmHg. [1]
  • Heart rhythm. Resting heart rate rose by 2 to 3 beats per minute on average, tachycardia was reported by 0.6% against 0.1%, and 0.3% had a heart conduction change against none on placebo. [1] The Canadian monograph also describes a slight lengthening of the PR interval on an ECG. [3]

What a reporting database adds

A 2025 analysis of nearly two decades of the US FDA adverse event reporting system looked at neurological reports for six GLP-1 medicines, liraglutide among them. Dizziness and presyncope, the feeling of being about to faint, were among the signals, and almost half of these reports came within 30 days of starting treatment. [4]

Such databases depend on voluntary reports. They can flag a pattern worth watching but cannot show how often dizziness happens or prove that the medicine caused it. [4] The trial figures above remain the better guide to frequency.

Other reasons for feeling dizzy

MedlinePlus separates light-headedness, a feeling you might faint, from vertigo, a spinning sensation. Light-headedness comes from too little blood reaching the brain, for example after standing quickly, with dehydration, a sudden fall in blood pressure, low blood sugar, flu or a cold, or from medicines that lower blood pressure. [5] If you take blood pressure tablets, the modest fall in pressure on Saxenda® is worth mentioning to your prescriber. [1][5]

Vertigo is more often an inner ear problem such as benign positional vertigo, labyrinthitis or Ménière disease. [5] Serious causes such as heart rhythm problems, stroke or internal bleeding usually bring other warning signs, including chest pain, a racing heart, slurred speech or vision change. [5]

Staying safe while it lasts

For light-headedness on standing, MedlinePlus suggests avoiding sudden changes in posture, getting up slowly and sitting for a moment before standing, and having something to hold on to. For vertigo, it suggests keeping still during attacks, avoiding sudden movements and increasing activity gradually. [5]

The EU summary asks for caution with driving or machines when dizzy, and the Canadian leaflet says not to drive if you feel dizzy. [2][3] If you are at risk of low blood sugar, your provider should explain how to recognise and treat it; the Medication Guide also asks you to check your blood sugar before and during Saxenda® if you have type 2 diabetes. [1] Drinking fluids to avoid dehydration is part of the same guidance. [1]

Saxenda® is a registered trademark of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.

When to get help

SignWho to contactHow fastSource
Dizziness with chest pain, an irregular or racing heartbeat, shortness of breath, weakness in an arm or leg, or a change in speech or visionEmergency number nowEmergencyMedlinePlus [5]
Fainting, or dizziness with swelling of the face or throat and trouble breathingStop Saxenda® and call your emergency numberEmergencyMedication Guide [1]; MedlinePlus [5]
Dizziness with sweating, shakiness or confusion if you take insulin or a sulfonylurea, or are a teen on Saxenda®Check blood sugar and treat as you were shown; contact your care teamTodayMedication Guide [1]; MedlinePlus [6]
Dizziness with trouble keeping fluids down, or very little urineYour provider the same day; seek urgent care if severeTodayMedlinePlus [5][7]
A racing or pounding heart at rest lasting several minutesYour prescriberTodayMedication Guide [1]
Dizziness for the first time, new or worse dizziness, or dizziness after taking a medicineYour doctorAt your next appointmentMedlinePlus [5]

Questions

Does Saxenda® make you dizzy?

It can: 6.9% of adults on Saxenda® reported dizziness in the trials against 5.0% on placebo, and 10.4% of teens against 3.2%. [1]

How long does Saxenda® dizziness last?

The labels say it was mainly reported in the first 12 weeks, or first three months in the EU wording, and was mostly mild to moderate and short-lived. [1][2][3]

Can I drive if I feel dizzy on Saxenda®?

The EU summary asks for caution with driving when dizziness occurs, and the Canadian leaflet says not to drive if you feel dizzy. [2][3] Low or high blood sugar can also affect your ability to drive. [3]

Does Saxenda® lower blood pressure?

Modestly. In the main trial, systolic pressure fell by 4.3 mmHg on Saxenda® against 1.5 mmHg on placebo, and low blood pressure events were reported by 1.1% against 0.5%. [1]

Is dizziness on Saxenda® a sign of low blood sugar?

It can be, especially with sweating, shakiness, hunger or confusion, and especially if you use insulin or a sulfonylurea or are a teenager on Saxenda®. [1][6]

Why might my teenager be dizzier than adults on Saxenda®?

The label does not say. Dizziness was reported by 10.4% of teens against 3.2% on placebo, and teens on Saxenda® also had more symptomatic low blood sugar, 15.2% against 4.0%. [1]

Sources

Sources checked on

  1. SAXENDA® (liraglutide) injection Prescribing Information and Medication Guide, Novo Nordisk Revised 02/2026. Sections 5.4, 5.5, 5.6, 5.8, 6.1 (Tables 2–3, Hypotension, Cardiac Conduction Disorders, text on asthenia and dizziness), 14.1 (Table 6) and Medication Guide.
  2. Saxenda: EPAR – Product Information (SmPC and package leaflet), European Medicines Agency Sections 4.7 and 4.8 (Table 4); package leaflet section 2.
  3. SAXENDA® (liraglutide injection) Product Monograph, Novo Nordisk Canada Inc. (Health Canada Drug Product Database) Date of authorization 10 September 2025. Section 7 (Driving, PR interval), 8.2 (Tables 3–4) and Patient Medication Information.
  4. Chen H et al. Pharmacovigilance analysis of neurological adverse events associated with GLP-1 receptor agonists based on the FDA Adverse Event Reporting System. Sci Rep 2025 FAERS disproportionality analysis; reports cannot show cause. PubMed abstract.
  5. Dizziness, MedlinePlus Medical Encyclopedia
  6. Low blood sugar, MedlinePlus Medical Encyclopedia
  7. Dehydration, MedlinePlus Medical Encyclopedia

Set up your lab tonight.

It takes a few minutes. Pep will be waiting.